Clinical Trial Update: 18F-FDG Metabolism Imaging Monitoring Non-small Cell Lung Cancer Curative Effect of Chemotherapy Multicenter Clinical Study [Phase 3]

View source ↗

Summary

A multicenter Phase 3 clinical trial assessing whether 18F-FDG PET imaging can monitor the effectiveness of chemotherapy in non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non-small-cell Lung Cancer | Phase 3 | Status: UNKNOWN